Suppr超能文献

[糖尿病视网膜病变患者血清中的缓激肽和血管紧张素转换酶与糖尿病黄斑水肿发生的预后(初步研究)]

[Bradykinin and angiotensin-converting enzyme in serum of patients with diabetic retinopathy and the prognosis of diabetic macular edema development (pilot study)].

作者信息

Neroev V V, Chesnokova N B, Kost O A, Okhotsimskaya T D, Pavlenko T A, Beznos O V, Binevsky P V, Lisovskaya O A

机构信息

Helmholtz National Medical center of Eye Diseases.

School of Chemistry, Lomonosov Moscow State University.

出版信息

Probl Endokrinol (Mosk). 2021 Aug 19;67(4):13-19. doi: 10.14341/probl12762.

Abstract

BACKGROUND

Diabetic macular edema (DME) is a microvascular complication of diabetic retinopathy. One of the key roles in the pathogenesis of DME may belong to the components of rennin-angiotensin and kallikrein-kinin systems: bradykinin (Bk) and angiotensin-converting enzyme (ACE).

PURPOSE

To determine the Bk and ACE concentration and ACE activity in serum of patients with proliferative diabetic retinopathy (PDR) and to estimate the significance of these parameters for the early diagnostic and prognosis of DMO.

MATERIALS AND METHODS

Serum was collected from the 2 groups of patients with II type diabetes. Group I (n=9) had DME, group II (n=27) had PDR without DME. Control group (n=14) consisted of adult volonteers without diabetes and ophthalmic diseases. Concentration of Bk and ACE was measured using ELISA kits, ACE activity was determined enzymatically with specific fluorogenic substrate.

RESULTS

Concentration of Bk in serum of patients without DME did not differ from one in controls (12,00 (9,70; 12,40) pg/ml) while all patients with DME had Bk level of 14,69 (13,68; 16,78) pg/ml that was significantly higher (p<0,01). In patients without DME ACE concentration (88,60 (77,30; 97,45) ng/ml) and ACE activity (6,8 (5,1;7,1) nmol/min·ml) were higher than normal (p<0,01) while in the case of DME concentration of ACE increased (77,36 (70,24; 86,29 ng/ml, p<0,01) and activity remained normal. The Bk/ACE concentrations ratio decreased in patients without DME and increased in those having DME.

CONCLUSION

Patients with DME have increased Bk concentration along with nearly normal ACE concentration that indicate predominance of Bk synthesis over its degradation that may lead to the DME development. The Bk/ACE ratio decrease in patients with uncomplicated PDR and increase significantly in ones with DME. It means that determination of Bk in serum of patients with PDR may be used for the prediction of DME development. The Bk/ACE concentrations ratio may be even more informative.

摘要

背景

糖尿病性黄斑水肿(DME)是糖尿病视网膜病变的一种微血管并发症。肾素 - 血管紧张素系统和激肽释放酶 - 激肽系统的成分:缓激肽(Bk)和血管紧张素转换酶(ACE)在DME发病机制中可能起关键作用。

目的

测定增殖性糖尿病视网膜病变(PDR)患者血清中的Bk和ACE浓度以及ACE活性,并评估这些参数对糖尿病性黄斑病变(DMO)早期诊断和预后的意义。

材料与方法

收集两组II型糖尿病患者的血清。第一组(n = 9)患有DME,第二组(n = 27)患有无DME的PDR。对照组(n = 14)由无糖尿病和眼科疾病的成年志愿者组成。使用ELISA试剂盒测量Bk和ACE的浓度,用特定的荧光底物酶法测定ACE活性。

结果

无DME患者血清中的Bk浓度与对照组无差异(12.00(9.70;12.40)pg/ml),而所有DME患者的Bk水平为14.69(13.68;16.78)pg/ml,显著更高(p<0.01)。无DME患者的ACE浓度(88.60(77.30;97.45)ng/ml)和ACE活性(6.8(5.1;7.1)nmol/min·ml)高于正常水平(p<0.01),而在DME情况下,ACE浓度升高(77.36(70.24;86.29)ng/ml,p<0.01)且活性保持正常。无DME患者的Bk/ACE浓度比值降低,而DME患者的该比值升高。

结论

DME患者的Bk浓度升高,而ACE浓度接近正常,这表明Bk合成超过其降解,这可能导致DME的发展。单纯PDR患者的Bk/ACE比值降低,而DME患者的该比值显著升高。这意味着测定PDR患者血清中的Bk可用于预测DME的发展。Bk/ACE浓度比值可能更具信息量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70ab/9753801/deeda532d450/problendo-67-12762-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验